Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Discovering US Market's Hidden Gems with Strong Financials

In This Article:

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 14% over the past year with earnings projected to grow by 14% annually. In this dynamic environment, identifying stocks with strong financials can be key to uncovering hidden gems that may offer potential opportunities for investors.

Top 10 Undiscovered Gems With Strong Fundamentals In The United States

Name

Debt To Equity

Revenue Growth

Earnings Growth

Health Rating

Morris State Bancshares

9.72%

4.93%

6.51%

★★★★★★

Wilson Bank Holding

NA

7.87%

8.22%

★★★★★★

Omega Flex

NA

0.39%

2.57%

★★★★★★

ASA Gold and Precious Metals

NA

7.47%

-26.86%

★★★★★★

Teekay

NA

-0.89%

62.53%

★★★★★★

Anbio Biotechnology

NA

8.43%

184.88%

★★★★★★

FRMO

0.08%

38.78%

45.85%

★★★★★☆

Gulf Island Fabrication

20.41%

-7.88%

41.10%

★★★★★☆

Pure Cycle

5.15%

-2.61%

-6.23%

★★★★★☆

Reitar Logtech Holdings

31.39%

231.46%

41.38%

★★★★☆☆

Click here to see the full list of 280 stocks from our US Undiscovered Gems With Strong Fundamentals screener.

Let's review some notable picks from our screened stocks.

ChromaDex

Simply Wall St Value Rating: ★★★★★★

Overview: ChromaDex Corporation is a bioscience company that specializes in developing products aimed at promoting healthy aging, with a market capitalization of approximately $666.19 million.

Operations: ChromaDex generates revenue primarily from consumer products, which account for $76.77 million, followed by ingredients at $19.81 million and analytical reference standards and services at $3.01 million.

ChromaDex, a bioscience firm dedicated to healthy aging solutions, has recently shown promising financial performance. The company reported a significant increase in net income for 2024 at US$8.55 million compared to a net loss of US$4.94 million the previous year, with sales reaching US$99.6 million from US$83.57 million in 2023. Earnings per share also improved to US$0.11 from a loss of US$0.07 per share last year, reflecting its strategic expansion and partnerships like those with Watsons and Amazon for its NIAGEN IV product line which could drive further growth despite potential risks such as regulatory hurdles and market reliance on NIAGEN's success.

NasdaqCM:CDXC Earnings and Revenue Growth as at Mar 2025
NasdaqCM:CDXC Earnings and Revenue Growth as at Mar 2025

Guaranty Bancshares

Simply Wall St Value Rating: ★★★★★★

Overview: Guaranty Bancshares, Inc. serves as the bank holding company for Guaranty Bank & Trust, N.A., with a market capitalization of $448.80 million.

Operations: Guaranty Bancshares generates revenue primarily from its banking segment, amounting to $120.82 million. The company has a market capitalization of $448.80 million.